Advertisement

Topics

Latest "Keen" News Stories

19:04 EST 17th February 2019 | BioPortfolio

Here are the most relevant search results for "Keen" found in our extensive news archives from over 250 global news sources.

More Information about Keen on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Keen for you to read. Along with our medical data and news we also list Keen Clinical Trials, which are updated daily. BioPortfolio also has a large database of Keen Companies for you to search.

Showing "Keen" News Articles 1–25 of 98

Relevant

Keen Eye, Iris Pharma partner to bring AI in ophthalmology studies

The partnership intends to offer Iris Pharma AI applications to make assays faster, more reliable and more efficient. Keen Eye’s advanced AI technology allows Iris Pharma to optimize the The post Keen Eye, Iris Pharma partner to bring AI in ophthalmology studies appeared first on Compelo Medical Devices.


Deals this week: Sitryx, Keen Eye, Accera

Sitryx has raised $30m in a Series A financing round led by SV Health Investors and Sofinnova Partners. The funds...Read More... The post Deals this week: Sitryx, Keen Eye, Accera appeared first on Drug Development Technology.

Investors keen to put money into AMR SMEs


UK to unveil £1bn life sciences investment

Government keen to show Britain remains attractive despite Brexit

Keen Eye and Iris Pharma Team up to Bring Artificial Intelligence in Ophthalmology Studies

Keen Eye, a French technology company specialized in image analysis for the life science industry, announced today a strategic partnership agreement with

For CDMOs, continuous manufacturing isn't an 'if,' but a 'how'

Contract services providers are receiving more interest from drugmakers keen on the technology's potential cost-savings and better efficiency.

Editorial: Airlines are among the companies keen on converting biomass to liquid fuel. An update of century-old chemical reaction could produce kerosene from biomass https://go.nature.com/2QOmTG8 

Editorial: Airlines are among the companies keen on converting biomass to liquid fuel. An update of century-old chemical reaction could produce kerosene from biomass https://go.nature.com/2QOmTG8 

US FDA to make decision on Shield Therapeutics’ Feraccru drug by end of July

The US is a huge and potentially lucrative market that Shield is understandably keen to crack

Bob Duggan: Meet the US biotech billionaire taking a 49% stake in Summit

Duggan is said to be keen to finance the development of new antibiotics, with many viruses becoming increasingly resistant to the current cohort already out there

Summit well-funded as it gears up for ridinilazole phase III trial early next year

Summit has £13.0mln in the bank, while its drugs have also been backed financially by external organisations keen to see new treatments come through

Rachel Mulcahy

bmj;364/jan22_6/l290/FAF1faRachel Mulcahy was born and grew up in Wimbledon and loved playing and watching tennis. She was also a keen skier and met her husband on a trip to Whistler, Canada.After...

Kirsty Paterson

bmj;363/nov26_6/k4726/FAF1faKirsty Paterson (previously Cleverly) started her obstetrics and gynaecology training in North East Thames in 2011. A keen surgeon, she was passionate about fetal medicine...

Malaria-Sniffing Pooches Might Help Save Lives

MONDAY, Oct. 29, 2018 -- With their keen sense of smell, dogs can track down bombs and drugs, but new research suggests they can also sniff out malaria in people. If confirmed by further studies, canines might someday be used to help spot malaria...

Probably Relevant

Researchers uncover new details in how the olfactory epithelium develops

Dogs, known for their extraordinarily keen senses of smell, can be trained to use their sensitive sniffers to find drugs, bombs, bed bugs, missing hikers and even cancer. Among dogs and other animals that rely on smell, at least one factor that may give them an advantage is a sheet of tissue in the nasal cavity.

Patient Files: 
Lupus and liver disease

At just 20 years old Kirsty Mills received a shock diagnosis of liver cirrhosis, following diagnoses of autoimmune hepatitis and lupus. She talks about her experiences with these conditions, and is keen to challenge the misconception that liver disease is all too often associated only with drug and alcohol abuse

Pharma Q3 Results Preview: J&J, Novartis & Roche

Investors are keen to see how J&J's Remicade is holding up to biosimilar competition, especially now that Zytiga generics are...   

GSK Puts Tail End Brands On The Block In India

GlaxoSmithKline is believed to be keen to divest close to a dozen tail-end brands across therapy groups including anti-infectives and...   

Early Career Physicians, Pharmacists, Keen on Working in Tech, Survey Finds

Rajiv Leventhal, Managing EditorA survey of 502 early career U.S. physicians and pharmacists revealed that 47 percent of these healthcare professionals are interested in working in the technology sector.

McKinsey Blog: Inspiring leadership in young scientists

McKinsey & Company has been an essential Partner at each of our GapSummits, and Dr Matthias Evers, Senior Partner, McKinsey & Company, Hamburg, has been a keen supporter of GBR. Dr Evers was a keynote speaker for GapSummit 2017, where he spoke on the need for teamwork and leadership skills in a life science career.

Roche Diagnostics Shows Keen Interest in Diagnostic Management Teams

I was slightly taken aback by a recent email blast I received from Roche Diagnostics with links to a current and planned complementary articles about Diagnostic Management Teams (DMTs) (see: DMT series). I have posted a number of blog notes in the past about DMTs (see, for example: First Diagnostic...

Oncologists' Off-Label Prescribing Pits Access Against Reimbursement

Off-label prescribing in oncology is undergoing a change: Payers are more restrictive in their reimbursement for off-label uses, while oncologists are keen to provide access to new immunotherapies. Medscape Oncology

Study sheds light on how brain lets animals hunt for food by following smells

(NYU Langone Health / NYU School of Medicine) Most animals have a keen sense of smell, which assists them in everyday tasks. Now, a new study led by researchers at NYU School of Medicine sheds light on exactly how animals follow smells.

KU Leuven researchers use sound waves to prevent small chemical reactors from clogging up

(KU Leuven) Companies are keen to use miniature chemical reactors to make pharmaceuticals and fine chemicals, but are discouraged by their tendency to clog up. Researchers at KU Leuven, Belgium, have now devised an elegant way of using sound waves to keep the chemicals flowing.

Elpis Biomed thrilled to be crowned 'Start-up Of The Year' at tech awards

Elpis Biomed's Dr Mark Kotter spoke to Proactive London's Andrew Scott after being voted the 2018 Cambridge Start-Up of the Year. Elpis is developing high quality human cells via its proprietary OPTi-OX platform. Kotter also discusses their fundraise which they're in the middle of. He says he's looking to raise up to £5mln and is keen to expand the investor portfolio.

Nudging does not necessarily improve decisions

(University of Zurich) Nudging, the concept of influencing people's behavior without imposing rules, bans or coercion, is an idea that government officials and marketing specialists alike are keen to harness, and itis often viewed as a one-size-fits-all solution. Now, a study by researchers from the University of Zurich puts things into perspective: Whether a nudge really does improve decisions de...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks